[1]陈 雨,卢业才.HMMR基因在结肠癌中的表达及其对患者预后的影响[J].医学信息,2023,36(12):8-12.[doi:10.3969/j.issn.1006-1959.2023.12.002]
　CHEN Yu,LU Ye-cai.Expression of HMMR Gene in Colon Cancer and its Effect on the Prognosis[J].Journal of Medical Information,2023,36(12):8-12.[doi:10.3969/j.issn.1006-1959.2023.12.002]
点击复制

HMMR基因在结肠癌中的表达及其对患者预后的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年12期
页码:
8-12
栏目:
生物信息学
出版日期:
2023-06-15

文章信息/Info

Title:
Expression of HMMR Gene in Colon Cancer and its Effect on the Prognosis
文章编号:
1006-1959（2023）12-0008-05
作者:
陈 雨; 卢业才
（安徽医科大学附属巢湖医院胃肠外科，安徽 巢湖 238000）
Author(s):
CHEN Yu; LU Ye-cai
(Department of Gastrointestinal Surgery,Chaohu Hospital of Anhui Medical University,Chaohu 238000,Anhui,China)
关键词:
结肠癌; HMMR; 信号通路; PI3K-AKT-mTOR
Keywords:
Colon cancer; HMMR; Signaling pathways; PI3K-AKT-mTOR
分类号:
R735.3+5
DOI:
10.3969/j.issn.1006-1959.2023.12.002
文献标志码:
A
摘要:
目的 采用生物学方法探究HMMR基因在结肠癌中的表达，分析其与结肠癌患者预后的关系。方法 利用R语言相关软件包对NCBI数据库中GSE140973样本进行筛选和分析获取差异表达基因，通过GO分析和KEGG分析进行功能和途径富集分析、并对其进行PPI网络构建，通过Cytoscape软件对PPI网络进行可视化以及获取Hub基因，通过GEPIA平台进行差异表达分析和生存分析，最终筛选出目标基因。结果 在GSE140973中共发现807个DEGs；GO分析和KEGG分析显示，DEGs主要富集在有丝分裂细胞周期、染色体分离、糖酵解/糖异生、细胞周期等过程中，进一步分析获得HMMR、SHCBP1、ERCC6L、ZWINT、FAM83D、CDCA2、SPC25、SKA1、KIAA0101、MND1共10个Hub基因；生存分析和差异表达分析显示，HMMR基因在结肠癌组织和正常组织中的表达不同，其表达与患者预后有关。结论 在结直肠癌组织中HMMR基因呈高表达，且HMMR基因高表达与结肠癌患者预后相关。
Abstract:
Objective To explore the expression of HMMR gene in colon cancer by biological method and analyze its relationship with the prognosis of colon cancer patients.Methods The R language related software package was used to screen and analyze the GSE140973 samples in the NCBI database to obtain differentially expressed genes. GO analysis and KEGG analysis were used to perform functional and pathway enrichment analysis, and PPI network construction was performed. The PPI network was visualized by Cytoscape software and Hub genes were obtained. Differential expression analysis and survival analysis were performed through the GEPIA platform, and the target genes were finally screened.Results A total of 807 DEGs were found in GSE140973. GO analysis and KEGG analysis showed that DEGs were mainly enriched in mitotic cell cycle, chromosome separation, glycolysis/gluconeogenesis, cell cycle and other processes. Further analysis obtained 10 Hub genes including HMMR, SHCBP1, ERCC6 L, ZWINT, FAM83 D, CDCA2, SPC25, SKA1, KIAA0101 and MND1. Survival analysis and differential expression analysis showed that the expression of HMMR gene was different in colon cancer tissues and normal tissues, and its expression was related to the prognosis of patients.Conclusion HMMR gene is highly expressed in colon cancer, and the high expression of HMMR gene is related to the prognosis of colon cancer patients.

参考文献/References:

[1]Mody K,Bekaii-Saab T.Clinical Trials and Progress in Metastatic Colon Cancer[J].Surgical Oncology Clinics of North America,2018,27(2):349-365.[2]Lee JJ,Chu E.An update on treatment advances for the first-line therapy of metastatic colorectal cancer[J].Cancer Journal,2007,13(5):276-281.[3]Dennis G,Sherman B,Da H,et al.DAVID: Database for Annotation, Visualization, and Integrated Discovery[J].Genome Biology,2003,4(5):P3.[4]Shannon P.Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks[J].Genome Research,2003,13(11):2498-2504.[5]Bader GD,Hogue CWV.An Automated Method for Finding Molecular Complexes in Large Protein Interaction Networks[J].BMC Bioinformatics,2003,4(1,article 2):2.[6]Schulc K,Nagy ZT,Kamp S,et al.Modular Reorganization of Signaling Networks during the Development of Colon Adenoma and Carcinoma[J].The Journal of Physical Chemistry B,2021,125(7):1716-1726.[7]Cai Y,Sheng Z,Chen Y,et al.LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis[J].Aging,2019,11(10):3041-3054.[8]Li X,Zuo H,Zhang L,et al.Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods[J].Frontiers in Oncology,2021,11:3379.[9]吴良银,李文丽,刘俊.HMMR预测肝细胞癌预后的生物信息学分析[J].国际检验医学杂志,2022,43(12):1454-1457.[10]Xu F,Guan Y,Xue L,et al.The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma[J].BMC Cancer,2020,20(1):1207.[11]He Z,Mei L,Connell M,et al.Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor[J].Cells,2020,9(4):819.[12]Chen H,Connell M,Mei L,et al.The non-motor adaptor HMMR dampens Eg5-mediated forces to preserve the kinetics and integrity of chromosome segregation[J].Molecular Biology of the Cell,2018,29(7):786-796.[13]Rui Z,Roostalu J,Surrey T,et al.Structural insight into TPX2-stimulated microtubule assembly[J].Elife,2017,6:e30959.[14]He Z,Mei L,Connell M,et al.Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor[J].Cells,2020,9(4):819.[15]熊超.结肠癌组织中RNF181、TPX2的表达量及其与癌细胞活力、血管新生的相关性分析[J].海南医学院学报,2017,23(14):1969-1971,1975.[16]Wei P,Zhang N,Xu Y,et al.TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer[J].Journal of Translational Medicine,2013,1(1):313.[17]Janku F,Yap TA,Meric-Bernstam F.Targeting the PI3K pathway in cancer: are we making headway?[J].Nat Rev Clin Oncol,2018,15(5):273-291.[18]胡晓青,于慧美,沈璐妍,等.PI3K/AKT/mTOR信号通路与线粒体稳态在疾病治疗中的作用[J].中国病理生理杂志,2021,37(11):2072-2076.[19]Liu M,Ran J,Zhou J.Non-canonical functions of the mitotic kinesin Eg5[J].Thoracic Cancer,2018,9(8):904-910.[20]Chu TLH,Connell M,Zhou L,et al.Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A[J].Molecular Cancer Research,2018,16(1):16-31.[21]Taherdangkoo K,Kazemi Nezhad SR,Hajjari MR,et al.miR-485-3p suppresses colorectal cancer via targeting TPX2[J].Bratisl Lek Listy,2020,121(4):302-307.[22]熊超.结肠癌组织中RNF181、TPX2的表达量及其与癌细胞活力、血管新生的相关性分析[J].海南医学院学报,2017,23(14):1969-1971,1975.

相似文献/References:

[1]苏周荣,杜东霖,魏正强.左半结肠癌伴梗阻一期切除吻合策略研究[J].医学信息,2018,31(10):51.[doi:10.3969/j.issn.1006-1959.2018.10.016]
　SU Zhou-rong,DU Dong-lin,WEI Zheng-qiang.Strategy of One-stage Resection and Anastomosis for Left Colon Cancer with Obstruction[J].Journal of Medical Information,2018,31(12):51.[doi:10.3969/j.issn.1006-1959.2018.10.016]
[2]石 磊,孙新增,李宝山,等.Ⅱ、Ⅲ期结肠癌患者辅助化疗XELOX方案、FOLFOX方案的临床疗效、不良反应及生活质量对比[J].医学信息,2018,31(13):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
　SHI Lei,SUN Xin-zeng,LI Bao-shan,et al.Clinical Efficacy,Adverse Reactions and Quality of Life of Adjuvant Chemotherapy XELOX and FOLFOX in Patients with Stage II and III Colon Cancer[J].Journal of Medical Information,2018,31(12):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
[3]王 超,范小华,张 力,等.下腔静脉畸形伴腹腔多脏器异位合并结肠癌1例[J].医学信息,2018,31(18):188.[doi:10.3969/j.issn.1006-1959.2018.18.062]
　WANG Chao,FAN Xiao-hua,ZHANG Li,et al.a Case of Inferior Vena Cava Malformation Associated with Multiple Abdominal Organ Ectopic Colon Cancer[J].Journal of Medical Information,2018,31(12):188.[doi:10.3969/j.issn.1006-1959.2018.18.062]
[4]黄富全.结合靶向药物综合治疗结肠癌肝及肝外转移术后7年1例报告[J].医学信息,2019,32(01):186.[doi:10.3969/j.issn.1006-1959.2019.01.061]
[5]葛菁茹,朱静雅,苏日新,等.以肺转移为首发表现的结肠癌预后分析[J].医学信息,2021,34(04):96.[doi:10.3969/j.issn.1006-1959.2021.04.025]
　GE Jing-ru,ZHU Jing-ya,SU Ri-xin,et al.Prognostic Analysis of Colon Cancer with Lung Metastasis as the First Manifestation[J].Journal of Medical Information,2021,34(12):96.[doi:10.3969/j.issn.1006-1959.2021.04.025]
[6]李 洋.北京市海淀区居民结肠癌防治知识知晓情况分析[J].医学信息,2021,34(08):141.[doi:10.3969/j.issn.1006-1959.2021.08.037]
　LI Yang.Analysis of Knowledge About Colon Cancer Prevention and Treatment Among Residents in Haidian District,Beijing[J].Journal of Medical Information,2021,34(12):141.[doi:10.3969/j.issn.1006-1959.2021.08.037]
[7]查作霖,陈福军.MicroRNA-613调控ATOH1和FMNL2对结肠癌发生发展的影响[J].医学信息,2021,34(17):83.[doi:10.3969/j.issn.1006-1959.2021.17.021]
　ZHA Zuo-lin,CHEN Fu-jun.ATOH1 and FMNL2 on the Occurrence and Development of Colon Cancer[J].Journal of Medical Information,2021,34(12):83.[doi:10.3969/j.issn.1006-1959.2021.17.021]
[8]侯丁丁,赵 力.Ⅱ~Ⅲ期结肠癌术后辅助化疗方案[J].医学信息,2021,34(18):6.[doi:10.3969/j.issn.1006-1959.2021.18.002]
　HOU Ding-ding,ZHAO Li.Adjuvant Chemotherapy After Surgery for Stage Ⅱ~Ⅲ Colon Cancer[J].Journal of Medical Information,2021,34(12):6.[doi:10.3969/j.issn.1006-1959.2021.18.002]
[9]韩 猛,薛三宝,倪 丰.CT与MRI术前诊断结肠癌及评价术后复发的价值[J].医学信息,2021,34(21):175.[doi:10.3969/j.issn.1006-1959.2021.21.050]
　HAN Meng,XUE San-bao,NI Feng.Value of CT and MRI in Preoperative Diagnosis and Postoperative Recurrence of Colon Cancer[J].Journal of Medical Information,2021,34(12):175.[doi:10.3969/j.issn.1006-1959.2021.21.050]
[10]操利超,巴 颖,卢晓萍,等.基于TCGA和GEO数据库构建结肠癌预后模型[J].医学信息,2021,34(24):27.[doi:10.3969/j.issn.1006-1959.2021.24.006]
　CAO Li-chao,BA Ying,LU Xiao-ping,et al.Prognostic Model of Colon Cancer Based on TCGA and GEO Database[J].Journal of Medical Information,2021,34(12):27.[doi:10.3969/j.issn.1006-1959.2021.24.006]

更新日期/Last Update: 1900-01-01